Page 32
Notes:
Journal of Clinical and Experimental Toxicology | Volume: 03 | ISSN: 2630-4570
allied
academies
November 04-05, 2019 | Prague, Czech Republic
2
nd
World Congress on
TOXICOLOGY AND APPLIED PHARMACOLOGY
Scorpion toxins as drug and pharmacological tolls candidates
Elisabeth Ferroni Schwartz
University of Brasilia, Brazil
S
corpions are known for their dangerous stings that can
result in severe consequences for humans, including
death. Neurotoxins present in their venoms are responsible
for their toxicity, and due to their medical relevance, toxins
have been themainmotive for scorpion toxins research field.
On the other hand, for thousands of years, scorpion venoms
have been applied in traditional medicine, mainly in Asia
and Africa. With the advent of novel methodologies for the
massive study and characterization of venom components,
several drug candidates have been found with the potential
to tackle many of the emerging global medical threats.
Scorpions have become a valuable source of biologically
active molecules, from novel antibiotics to potential
anticancer therapeutics. Due to their pharmacological
action on ion channels and their clinical relevance,
neurotoxins have drawn attention as useful scaffolds for the
development of drugs, and new pharmacological tolls. Most
of the knowledge about the structure and functioning of ion
channels was obtained using animal toxins that modulate
these membrane proteins, especially scorpion toxins. This
talk will summarize the scorpion toxins that are the most
promising candidates for drugs and pharmacological tolls.
Biography
Elisabeth Ferroni Schwartz has completed her PhD from São Paulo
University, SP, Brazil. She is professor of University of Brasilia, DF, Brazil.
She has over 60 publications that have been cited over 1200 times, and
her publication H-index is 21. Her main research subjects have been
scorpion toxins, and ion channel modulators.
e:
beth.ferroni@gmail.comElisabeth Ferroni Schwartz, J Clin Exp Tox, Volume: 03
DOI: 10.35841/2630-4570-C2-009